Christina Jamieson
- Immunology top 5%
- Immunotherapy and Immune Responses 7
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- PARP inhibition in cancer therapy 3
- Bone health and treatments 3
- Cancer Research top 5%
- NF-κB Signaling Pathways 5
-
- Prostate Cancer Treatment and Research 17
-
- Acute Myeloid Leukemia Research 3
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Michael KarinMassimo AmmiranteShabnam ShalapourChristopher J. KaneKeith R. YamamotoRanjan SenAmy StrasnerKelsey C. Martin
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (4 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Christina Jamieson
39 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Immunology 734
- Oncology 708
- Cancer Research 335
- Molecular Biology 665
- Pulmonary and Respiratory Medicine 275
Countries citing papers authored by Christina Jamieson
This map shows the geographic impact of Christina Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Jamieson more than expected).
Fields of papers citing papers by Christina Jamieson
This network shows the impact of papers produced by Christina Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Jamieson. The network helps show where Christina Jamieson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christina Jamieson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 17 | |
| 9 | 2018 | 54 | |
| 10 | 2018 | 15 | |
| 11 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapybreakdown → | 2015 | 429 |
| 12 | 2014 | 174 | |
| 13 | 2012 | 29 | |
| 14 | 2011 | 24 | |
| 15 | 2010 | 1 | |
| 16 | 2010 | 24 | |
| 17 | 2009 | 2 | |
| 18 | 2006 | 181 | |
| 19 | 2004 | 3 | |
| 20 | 1989 | 24 |
About Christina Jamieson
Christina Jamieson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), NF-κB Signaling Pathways (5 papers), PARP inhibition in cancer therapy (3 papers), Acute Myeloid Leukemia Research (3 papers), Bone health and treatments (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Immunology (734 citations), Oncology (708 citations) and Cancer Research (335 citations). Christina Jamieson has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Michael Karin, Massimo Ammirante, Shabnam Shalapour, Christopher J. Kane, Keith R. Yamamoto, Ranjan Sen, Amy Strasner, Kelsey C. Martin, Daniel H. Geschwind and Sang-Hyun Choi. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.